185 related articles for article (PubMed ID: 35244768)
1. Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells.
Hisamori S; Mukohyama J; Koul S; Hayashi T; Rothenberg ME; Maeda M; Isobe T; Valencia Salazar LE; Qian X; Johnston DM; Qian D; Lao K; Asai N; Kakeji Y; Gennarino VA; Sahoo D; Dalerba P; Shimono Y
J Gastroenterol; 2022 Jun; 57(6):407-422. PubMed ID: 35244768
[TBL] [Abstract][Full Text] [Related]
2. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
3. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
Dimri M; Kang M; Dimri GP
Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
[TBL] [Abstract][Full Text] [Related]
4. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 Functions as a Competing Endogenous RNA to Regulate BMI1 Expression by Sponging miR-200c/miR-203 in the Control of the Differentiation of Pulp Cells.
Jin H; Zhao J; Li C
Biochem Genet; 2021 Oct; 59(5):1260-1277. PubMed ID: 33772374
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
[TBL] [Abstract][Full Text] [Related]
7. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X
Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
Shimono Y; Zabala M; Cho RW; Lobo N; Dalerba P; Qian D; Diehn M; Liu H; Panula SP; Chiao E; Dirbas FM; Somlo G; Pera RA; Lao K; Clarke MF
Cell; 2009 Aug; 138(3):592-603. PubMed ID: 19665978
[TBL] [Abstract][Full Text] [Related]
9. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of miR-200c in colorectal cancer through BMI1.
Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R
J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714
[TBL] [Abstract][Full Text] [Related]
11. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
[TBL] [Abstract][Full Text] [Related]
13. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
[TBL] [Abstract][Full Text] [Related]
14. miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.
Mukohyama J; Isobe T; Hu Q; Hayashi T; Watanabe T; Maeda M; Yanagi H; Qian X; Yamashita K; Minami H; Mimori K; Sahoo D; Kakeji Y; Suzuki A; Dalerba P; Shimono Y
Cancer Res; 2019 Oct; 79(20):5151-5158. PubMed ID: 31416845
[TBL] [Abstract][Full Text] [Related]
15. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
16. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
17. miR-27b shapes the presynaptic transcriptome and influences neurotransmission by silencing the polycomb group protein Bmi1.
Poon VY; Gu M; Ji F; VanDongen AM; Fivaz M
BMC Genomics; 2016 Oct; 17(1):777. PubMed ID: 27716060
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
19. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
Dimri M; Cho JH; Kang M; Dimri GP
J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
[TBL] [Abstract][Full Text] [Related]
20. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
Liu S; Tetzlaff MT; Cui R; Xu X
Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
